This image reminded me that narratives, however old, might still have something to offer.
The launch in the UK of Lurisidone began in August 2014. My previous post on Lurasidone (Latuda) which has now been marketed in the UK followed the financial interests of … Continue reading Lurasidone – financial conflicts of interest
INTRODUCTION: In Part II of my review of dementia I am going to offer my personal “journey” through policy developments in the UK over the year past. To help you … Continue reading PART II: Dementia: who is in the “driving seat”?